Full Text View
Tabular View
No Study Results Posted
Related Studies
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
This study is currently recruiting participants.
Study NCT00265200   Information provided by James Graham Brown Cancer Center
First Received: December 12, 2005   Last Updated: May 19, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma, Non-Small Cell Lung
Carcinoma, Small Cell Lung
Metastases
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Lung Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Adenocarcinoma
Carcinoma, Neuroendocrine
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplastic Processes
Neuroectodermal Tumors
Neuroendocrine Tumors
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
zoledronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
James Graham Brown Cancer Center
University of Louisville
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services